Announces new strategic drug discovery partnership with Charles River Opens new office dedicated to drug discovery and potential development of novel CNS therapeutics BOSTON --(BUSINESS WIRE)--Feb. 6, 2020-- Karuna Therapeutics, Inc. (Nasdaq: KRTX), a clinical-stage biopharmaceutical company

BOSTON --(BUSINESS WIRE)--Jan. 9, 2020-- Karuna Therapeutics, Inc. (Nasdaq: KRTX), a clinical-stage biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with disabling and potentially fatal neuropsychiatric disorders and pain, today